Regis Corporation Files 10-Q for Period Ending March 31, 2024

TL;DR

<b>Regis Corporation filed its Q3 2024 10-Q, detailing financial performance and equity changes.</b>

AI Summary

REGIS CORP (RGS) filed a Quarterly Report (10-Q) with the SEC on May 1, 2024. Regis Corporation filed a 10-Q report for the period ending March 31, 2024. The filing covers the third quarter of fiscal year 2024. Key financial data points and segment revenues are detailed within the report. The report includes information on common stock, additional paid-in capital, accumulated other comprehensive income, and retained earnings as of March 31, 2024. The company's fiscal year ends on June 30.

Why It Matters

For investors and stakeholders tracking REGIS CORP, this filing contains several important signals. This filing provides investors with the latest quarterly financial snapshot of Regis Corporation, crucial for assessing performance and making investment decisions. Understanding the segment revenues and equity structure helps in evaluating the company's operational health and financial stability.

Risk Assessment

Risk Level: medium — REGIS CORP shows moderate risk based on this filing. The filing is a standard 10-Q, which provides a routine update on financial performance. Specific risks are not detailed in this header information, but the nature of a 10-Q implies ongoing business operations with inherent market and operational risks.

Analyst Insight

Review the detailed financial statements and segment performance within the 10-Q to understand revenue trends and profitability drivers for Regis Corporation.

Key Numbers

• 2024-03-31 — Report Date (Conformed Period of Report)
• 2024-05-01 — Filing Date (As of Date)
• 0630 — Fiscal Year End (Fiscal Year End)
• Q3 — Quarter (Fiscal Quarter)

Key Players & Entities

• REGIS CORP (company) — Filer
• RGS (company) — Ticker Symbol
• MINNEAPOLIS (company) — City
• MN (company) — State
• 9529477777 (dollar_amount) — Business Phone

FAQ

Industry Context

Regis Corporation operates in the personal services industry, specifically focusing on hair salons and related services.

Regulatory Implications

The filing is made under the Securities Exchange Act of 1934, requiring public companies to submit regular financial reports.

What Investors Should Do

1. Analyze the revenue breakdown by segment to identify growth areas and underperforming segments.
2. Examine changes in equity accounts (Common Stock, Retained Earnings, etc.) for insights into capital structure and profitability.
3. Compare current quarter performance against historical data (if available in the full report) to identify trends.

Key Dates

• 2024-03-31: Quarter End — End of the reporting period for the 10-Q filing.
• 2024-05-01: Filing Date — Date the 10-Q report was officially filed with the SEC.

Year-Over-Year Comparison

This is the 10-Q filing for the period ending March 31, 2024. A comparison to the previous filing (likely a 10-Q for the period ending December 31, 2023, or an annual 10-K) would require access to that document.

Key Financial Figures

• $0.05 — ange on which registered Common Stock, $0.05 par value RGS The Nasdaq Stock Market L

Filing Documents

• rgs-20240331.htm (10-Q) — 1051KB
• rgs-20240331xex311.htm (EX-31.1) — 10KB
• rgs-20240331xex312.htm (EX-31.2) — 10KB
• rgs-20240331xex32.htm (EX-32) — 6KB
• 0000716643-24-000020.txt (&nbsp;) — 5760KB
• rgs-20240331.xsd (EX-101.SCH) — 44KB
• rgs-20240331_cal.xml (EX-101.CAL) — 86KB
• rgs-20240331_def.xml (EX-101.DEF) — 182KB
• rgs-20240331_lab.xml (EX-101.LAB) — 491KB
• rgs-20240331_pre.xml (EX-101.PRE) — 341KB
• rgs-20240331_htm.xml (XML) — 824KB

Financial Statements (Unaudited)

Financial Statements (Unaudited): Condensed Consolidated Balance Sheets as of March 31, 2024 and June 30, 2023 3 Condensed Consolidated Statements of Operations for the Three and Nine Months Ended March 31, 2024 and 2023 4 Condensed Consolidated Statements of Comprehensive Loss for the Three and Nine Months Ended March 31, 2024 and 2023 5 Condensed Consolidated Statements of Shareholders' Deficit for the Three and Nine Months Ended March 31, 2024 and 2023 6 Condensed Consolidated Statements of Cash Flows for the Nine Months Ended March 31, 2024 and 2023 7 Notes to Condensed Consolidated Financial Statements 8 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 22 Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 32 Item 4.

Controls and Procedures

Controls and Procedures 32 Part II. Other Information 33 Item 1.

Legal Proceedings

Legal Proceedings 33 Item 1A.

Risk Factors

Risk Factors 33 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 36 Item 5. Other Information 36 Item 6. Exhibits 37

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Financial Statements (Unaudited)

Item 1. Financial Statements (Unaudited) REGIS CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) As of March 31, 2024 and June 30, 2023 (Dollars in thousands, except per share data) March 31, 2024 June 30, 2023 ASSETS Current assets: Cash and cash equivalents (Note 7) $ 5,886 $ 9,508 Receivables, net 9,514 10,885 Inventories, net 720 1,681 Other current assets 11,656 15,164 Total current assets 27,776 37,238 Property and equipment, net 5,437 6,422 Goodwill (Note 1) 173,345 173,791 Other intangibles, net 2,518 2,783 Right of use asset (Note 8) 311,120 360,836 Other assets 23,511 26,307 Total assets $ 543,707 $ 607,377 LIABILITIES AND SHAREHOLDERS' DEFICIT Current liabilities: Accounts payable $ 9,947 $ 14,309 Accrued expenses 25,693 30,109 Short-term lease liability (Note 8) 73,485 81,917 Total current liabilities 109,125 126,335 Long-term debt, net (Note 9) 179,718 176,830 Long-term lease liability (Note 8) 249,317 291,901 Other non-current liabilities 41,369 49,041 Total liabilities 579,529 644,107 Commitments and contingencies (Note 6) Shareholders' deficit: Common stock, $ 0.05 par value; issued and outstanding, 2,279,948 and 2,277,828 common shares at March 31, 2024 and June 30, 2023, respectively (Note 1) 114 114 Additional paid-in capital (Note 1) 68,040 66,764 Accumulated other comprehensive income 8,796 9,023 Accumulated deficit ( 112,772 ) ( 112,631 ) Total shareholders' deficit ( 35,822 ) ( 36,730 ) Total liabilities and shareholders' deficit $ 543,707 $ 607,377 _______________________________________________________________________________ The accompanying notes are an integral part of the unaudited Condensed Consolidated Financial Statements. 3 REGIS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) For the Three and Nine Months Ended March 31, 2024 and 2023 (Dollars and shares in thousands, except per share amounts) Three Months Ended March 31, Nine Months E

View Full Filing

View this 10-Q filing on SEC EDGAR